Sociodemographic Factors Affect Prostate CA Treatment Initiation

This article originally appeared here.
Share this content:
Sociodemographic Factors Affect Prostate CA Treatment Initiation
Sociodemographic Factors Affect Prostate CA Treatment Initiation

THURSDAY, Aug. 18, 2016 (HealthDay News) -- For men with low-risk prostate cancer undergoing active surveillance, sociodemographic factors are associated with initiation of active treatment, according to a study published in the September issue of The Journal of Urology.

Scott P. Kelly, Ph.D., from the Georgetown University Medical Center in Washington, D.C., and colleagues conducted a retrospective study of men diagnosed with low-risk prostate cancer between 2004 and 2012 who did not receive any treatment within the first year of diagnosis. Patients were followed for at least two years to determine the factors associated with time from diagnosis to active treatment.

The researchers identified 2,228 eligible men, of whom 27 percent began active treatment at a median of 2.9 years. Independent of baseline and follow-up clinical measures, non-Hispanic black men were slightly more likely to begin active treatment than non-Hispanic white men (hazard ratio [HR], 1.3; 95 percent confidence interval [CI], 1.0 to 1.7). Of those men who remained on observation, the rate of rebiopsy within 24 months of diagnosis was slightly lower for non-Hispanic black men than non-Hispanic white men (HR, 0.70; 95 percent CI, 0.6 to 1.0). Independent of race, initiation of active treatment was associated with Gleason grade progression (HR, 3.3; 95 percent CI, 2.7 to 4.1) and prostate-specific antigen doubling time less than 48 months (HR, 2.9; 95 percent CI, 2.3 to 3.7).

"Sociodemographic factors such as ethnicity and education may independently influence the patient decision to pursue active treatment and serial biopsies during active surveillance," the authors write. "These factors are important for further studies of prostate cancer treatment decision making."

Abstract
Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Better Stem Cell Tx Outcomes for Younger MS Patients

Better Stem Cell Tx Outcomes for Younger MS ...

Results support additional trials of autologous hematopoietic stem cell transplantation

OD Risk Up in Children Whose Mothers Are Prescribed Opioids

OD Risk Up in Children Whose Mothers Are ...

Second study finds opioids stored unsafely in many households with children

AAP Urges Doctors Not to Punish Pregnant Women for Opioid Use

AAP Urges Doctors Not to Punish Pregnant Women ...

Group says better prevention and treatment, not jail time, would stem surge in drug-addicted newborns

is free, fast, and customized just for you!

Already a member?

Sign In Now »